Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$318,618,028
+$7,319,333 QoQ
Shares Held
2,033,040
-0.2% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
3.18%
of 13F equity value
Holder Rank
#17
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cullen Capital Management, LLC holds $1,067,869,600 across 8 Drug Manufacturers - General names. NVS ranks #1 (29.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
This page
|
2,033,040 | $318,618,028 | |
| 2 | JNJ |
Johnson & Johnson
|
1,099,077 | $279,132,585 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,016,795 | $259,158,157 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,132,367 | $65,246,986 | |
| 5 | PFE |
Pfizer Inc
|
2,447,200 | $58,928,576 | |
| 6 | NVO |
Novo Nordisk A S
|
1,224,955 | $58,724,342 | |
| 7 | SNY |
Sanofi
|
615,593 | $26,261,197 | |
| 8 | ABBV |
AbbVie Inc.
|
7,152 | $1,799,729 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $318,618,028 | 2,033,040 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $311,298,695 | 2,037,962 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $286,879,344 | 2,080,796 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $265,505,146 | 2,070,377 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $253,740,060 | 2,096,852 | Shares | Sole | 2025-09-30 | |
| 2025-03-31 | $235,076,092 | 2,108,684 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $209,860,594 | 2,156,619 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $259,021,359 | 2,251,968 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $305,580,761 | 2,870,381 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $282,879,533 | 2,924,424 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $164,504,160 | 1,629,238 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $276,530,444 | 2,714,809 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $282,133,259 | 2,795,890 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $318,320,276 | 3,460,003 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $252,901,322 | 2,787,713 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $263,547,420 | 3,467,273 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $284,302,453 | 3,363,332 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $289,160,030 | 3,295,271 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $245,145,871 | 2,802,628 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $245,228,615 | 2,998,638 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $261,638,637 | 2,867,587 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $221,621,260 | 2,592,668 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $49,578,205 | 525,026 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $56,083,547 | 644,935 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $56,648,724 | 648,600 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $63,125,369 | 765,620 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||